Written by The US Healthcare Cold Chain Logistics Market is growing as the healthcare industry increasingly depends on reliable temperature-controlled supply chains. The market was valued at USD 1,233.75 million in 2024 and is projected to reach USD 1,937.25 million by 2035, expanding at a CAGR of 4.19% during 2025–2035. The growing use of temperature-sensitive pharmaceuticals, biologics, vaccines, and clinical trial materials is supporting demand for specialized logistics services.
Technology is becoming a major part of modern healthcare cold chain operations. Real-time temperature monitoring, automated temperature control, IoT-enabled tracking, and improved data visibility can help logistics providers maintain product integrity throughout transportation and storage. These capabilities are particularly important for healthcare products where even small temperature deviations can affect quality and usability.
Pharmaceuticals represent the dominant application area, while vaccines are identified as one of the fastest-growing segments. Hospitals account for the largest end-user share, whereas biotechnology companies are experiencing strong growth as demand for advanced biologics and personalized medicine increases. Refrigerated logistics remains particularly important, while frozen solutions are gaining attention for products requiring deeper temperature control.
The future of the US healthcare cold chain sector will be shaped by regulatory requirements, biopharmaceutical expansion, healthcare e-commerce, and investments in smarter logistics infrastructure. Sustainable packaging, automated storage systems, and advanced tracking technologies are expected to create new opportunities. Major companies active in the market include Thermo Fisher Scientific, UPS Healthcare, FedEx Healthcare, DHL Supply Chain, Kuehne + Nagel, Cardinal Health, McKesson Corporation, AmerisourceBergen, and Panalpina.
Dive into related studies for a broader industry perspective:
Ai Drug Discovery Market Volume
Animal Health Market Distribution